Viewing StudyNCT00126191



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126191
Status: TERMINATED
Last Update Posted: 2013-05-23
First Post: 2005-08-02

Brief Title: Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Burkitt Lymphoma
Non-Hodgkins Lymphoma
Atypical Burkitt Lymphoma
Keywords:
Name View
Burkitt Lymphoma View
atypical Burkitt lymphoma View
Non-Hodgkins Lymphoma View
rituximab View